Skip to content

Multimodal assessment of post-stroke walking function - a clinical study based on lower limb robot and dual task training combined with diffusion tensor imaging technology

Multimodal assessment of post-stroke walking function - a clinical study based on lower limb robot and dual task training combined with diffusion tensor imaging technology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115695
Enrollment
Unknown
Registered
2025-12-30
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post stroke walking dysfunction

Interventions

Control group A:Routine rehabilitation therapy using lower limb rehabilitation robots
Control Group B:Dual task training routine rehabilitation therapy
Test Group C:Synchronized dual task training of lower limb rehabilitation robots for routine rehabilitation treatment

Sponsors

Chongqing jiangbei hospital of traditional chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Complies with the "Chinese Guidelines for the Diagnosis and Treatment of Cerebral Hemorrhage (2019)" formulated by the Neurology Branch of the Chinese Medical Association, and refers to the diagnostic criteria of the "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2023" formulated by the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association, confirmed by head CT or MRI, and with a disease duration of = 17 or MoCA >= 24; 6. Be able to follow clinical treatment plans and sign informed consent forms for subjects;

Exclusion criteria

Exclusion criteria: 1. Individuals with walking dysfunction prior to stroke; 2. Individuals with visual impairments or partial neglect; 3. Individuals with severe cognitive impairment or post-stroke depression; 4. Individuals with metal implants in their bodies, such as pacemakers and other metal devices; 5. Suffering from serious underlying diseases, such as NYHA heart function level 4 or severe COPD; 6. Participants who participate in other clinical trials during the same period.

Design outcomes

Primary

MeasureTime frame
Fugle Meyer Scale;

Secondary

MeasureTime frame
Functional Independence Assessment Scale (FIM);Magnetic resonance diffusion tensor imaging (DTI) FA value.;Berg Balance Scale;Stand up Walking Test;Holden Walking Function Grading;10 meter Walking Ability Test;

Countries

China

Contacts

Public ContactZhang Boyu

Chongqing jiangbei hospital of traditional chinese medicine

5662443@qq.com+86 23 6775 7401

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026